Effectiveness of endovascular therapy for patients with acute ischemic stroke: A meta-analysis of randomized controlled trials.
This meta-analysis of published randomized controlled trials (RCTs) aimed to investigate the efficacy and safety of endovascular therapy (ET) for patients with Acute ischemic stroke (AIS). The summary relative risks (RRs) with corresponding 95% confidence intervals (CIs) were calculated to measure the effectiveness of ET using a random-effects model. Thirteen RCTs including 3,408 patients were identified among 2,851 initial electronic citations. Overall, the summary RR indicated that ET significantly increased the incidence of a Modified Rankin Scale score of 0-2 (RR, 1.50; P<0.001), asymptomatic intracerebral hemorrhage (IH) (RR, 1.42; P=0.001), subarachnoid hemorrhage (SAH) (RR, 2.36; P=0.001), and major complications due to non-intracerebral bleeding (MCNB) (RR, 1.47; P=0.014). However, ET had no significant effects on the risk of 7-day death (P=0.827); death after 30 days (P=0.085); symptomatic IH (P=0.288); type 1 (P=0.413), type 2 (P=0.300), and total parenchymal hematoma (P=0.160); intraventricular hemorrhage (P=0.244); early neurologic deterioration (P=0.570); recurrent stroke (P=0.830); and symptomatic edema (P=0.485). The findings of this meta-analysis suggest the incidence of a Modified Rankin Scale score of 0-2 in patients received ET was significantly increased. Moreover, the harmful effects of ET might exist due to greater risk of asymptomatic IH, SAH, and MCNB, and these results should be verified by further large-scale long-term RCT.